The Benign Prostatic Hyperplasia Treatment Market Size was valued at USD 11.2 Billion in 2022 and is projected to grow from USD 11.8 Billion in 2023 to USD 18.1 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.50% during the forecast period (2023 - 2032). Benign Prostatic Hyperplasia (BPH) is a prevalent condition among aging men, characterized by the non-cancerous...